Comparing how cardiovascular procedures are approved and used across rich countries
Official title: Comparing approval, adoption/de-adoption and outcomes for advanced cardiovascular procedures across high-income countries
Funded at Harvard Medical School · NIH-11596351 · Data updated 2026-11-12
This grant looks at how different high-income countries decide to approve, use, and stop using newer heart procedures to understand why outcomes and costs differ.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | February 21, 2024 |
| Project end | January 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $16,875 |
| NIH project number | 3R01HL167887-03S2 |
| Project ID | NIH-11596351 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable to individual patient participation; the study analyzes health systems and treatments across populations.
✕Less likely to help
Direct benefit to individual patients is not the primary aim; findings may influence future policy and practice.
What this research studies
If funded, researchers will build on an established international network to compare how health technology assessments influence the adoption of cardiovascular treatments. They will analyze data across countries to see how decisions about coverage and reimbursement relate to actual practice and patient outcomes. The aim is to identify factors that drive high spending without corresponding improvements in heart-health results, and to inform better, evidence-based policies.
Why it matters
Potential benefit: It could help shape policies that improve heart care efficiency and outcomes while reducing unnecessary spending.
How similar studies have gone: Prior IHSRC work has connected HTA processes to treatment adoption, showing feasibility of international comparisons.
Where this research is happening
-
Harvard Medical School
Boston, United States Active
Researchers
- Principal investigator: Landon, Bruce E. — Harvard Medical School
- Study coordinator: Landon, Bruce E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.